Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma

Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma

Objective(s): CD44 is a member of the cell adhesion molecules family. Naturally, CD44S, along with CD44V3 influence the cell motility, migration, and adhesion, while in tumor cells they lead to tumor invasion, progression, and metastasis. The purpose of this research is to evaluate the CD44S and CD...

Full description

Bibliographic Details
Main Authors:	Atena Mansouri, Ali Mohammad Foroughmand, Mohammad Reza Abbaszadegan, Bahram Memar, Reihaneh Alsadat Mahmoudian, Mehran Gholamin
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2015-04-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	CD44 V3 CD44 S Esophageal squamous cell- carcinoma Real-time PCR
Online Access:	http://ijbms.mums.ac.ir/pdf_4287_0ad109dd8725003a8fa62c30141ffb73.html

Similar Items

Development of a Novel Anti−CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas
by: Nohara Goto, et al.
Published: (2022-05-01)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
by: Lucía Montero-Montero, et al.
Published: (2020-09-01)

The Role of CD44 in Disease Pathophysiology And Targeted Treatment
by: Andre R. Jordan, et al.
Published: (2015-04-01)

Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C<sub>44</sub>Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas
by: Kenichiro Ishikawa, et al.
Published: (2023-06-01)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
by: Susu Han, et al.
Published: (2019-02-01)

Role of MAML1 in targeted therapy against the esophageal cancer stem cells
by: Meysam Moghbeli, et al.
Published: (2019-04-01)

A study on the expression of CD44 adhesion molecule in oral squamous cell carcinoma and its correlation with tumor histological grading
by: Srilalitha Kaza, et al.
Published: (2018-01-01)

The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development
by: Bruce M. Boman, et al.
Published: (2023-12-01)

CD44 related stemness maneuvers oral squamous cell carcinoma biology
by: Ankita Tandon, et al.
Published: (2022-01-01)

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
by: Rita Azevedo, et al.
Published: (2018-06-01)

Obesogenic and diabetic effects of CD44 in mice are sexually dimorphic and dependent on genetic background
by: Melissa VerHague, et al.
Published: (2022-04-01)

Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
by: Aseel Kamil Mohammed Al-mosawi, et al.
Published: (2020-04-01)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
by: Luísa Vieira Codeço Marques, et al.
Published: (2018-10-01)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
by: Ingrīda Čēma, et al.
Published: (2021-11-01)

A Novel Anti-CD44 Variant 9 Monoclonal Antibody C<sub>44</sub>Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers
by: Mayuki Tawara, et al.
Published: (2023-04-01)

Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C<sub>44</sub>Mab-9 for Multiple Applications against Colorectal Carcinomas
by: Ryo Ejima, et al.
Published: (2023-02-01)

CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
by: Pouyan Amini Shakib, et al.
Published: (2015-01-01)

Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C<sub>44</sub>Mab-108 for Immunohistochemistry
by: Hiroyuki Suzuki, et al.
Published: (2023-02-01)

CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
by: Min Fang, et al.
Published: (2016-11-01)

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C<sub>44</sub>Mab-6 Was Established for Multiple Applications
by: Hiroyuki Suzuki, et al.
Published: (2023-05-01)

CD44 In Sarcomas: A Comprehensive Review and Future Perspectives
by: Enrique Fernández-Tabanera, et al.
Published: (2022-06-01)

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic Carcinomas
by: Yuma Kudo, et al.
Published: (2023-04-01)

Investigation of prognostic significance of CD44 expression in women with vulvar squamous cell carcinoma
by: Yakup Yalcin, et al.
Published: (2019-12-01)

Predictive value of ALDH1 and CD44 positivity for radiotherapy response and prognosis in early-stage glottic laryngeal squamous cell carcinoma
by: Ozgur Surmelioglu, et al.
Published: (2022-06-01)

Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C<sub>44</sub>Mab-34, for Multiple Applications against Oral Carcinomas
by: Hiroyuki Suzuki, et al.
Published: (2023-04-01)

Evaluation of the Correlation between CD44, Tumor Prognosis and the 5-Year Survival Rate in Patients with Oral Tongue SCC
by: Reza Kaboodkhani, et al.
Published: (2016-11-01)

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
by: Linda T. Senbanjo, et al.
Published: (2019-07-01)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
by: Jun Zhang, et al.
Published: (2021-11-01)

Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44
by: Roland K. Chiu, et al.
Published: (1999-11-01)

Targeting the pentraxin 3/CD44 axis: A potential treatment for pulmonary fibrosis
by: Shia Vang, et al.
Published: (2023-02-01)

Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands
by: Fonthip Laohavisudhi, et al.
Published: (2022-05-01)

Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer
by: Kenji Tsuchihashi, et al.
Published: (2022-07-01)

RNA-binding proteins regulating the CD44 alternative splicing
by: Diana Maltseva, et al.
Published: (2023-12-01)

Alcohol Metabolism Enriches Squamous Cell Carcinoma Cancer Stem Cells That Survive Oxidative Stress via Autophagy
by: Masataka Shimonosono, et al.
Published: (2021-10-01)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01)

1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line
by: Eun-Young Kim, et al.
Published: (2022-11-01)

CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01)

Expression of MMP-14 and CD44 associated with proliferation of retinoblastoma cells
by: Hendrian D. Soebagjo, et al.
Published: (2019-06-01)

Astrocytic CD44 Deficiency Reduces the Severity of Kainate-Induced Epilepsy
by: Patrycja K. Kruk, et al.
Published: (2023-05-01)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
by: Si D, et al.
Published: (2020-02-01)